Thomas Perone
Compliance Officer bij OVID THERAPEUTICS INC.
Vermogen: 38 697 $ op 30-04-2024
Actieve functies van Thomas Perone
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OVID THERAPEUTICS INC. | Compliance Officer | - | - |
Algemeen Adviseur | 21-03-2019 | - | |
Bedrijfssecretaris | 21-03-2019 | - |
Loopbaan van Thomas Perone
Eerdere bekende functies van Thomas Perone
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CELGENE | Algemeen Adviseur | 01-04-2006 | - |
Bedrijfssecretaris | 01-06-2014 | 01-05-2018 | |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Algemeen Adviseur | 01-12-2001 | 01-04-2006 |
Proskauer Rose LLC | Corporate Officer/Principal | - | - |
Opleiding van Thomas Perone
Rutgers State University of New Jersey | Undergraduate Degree |
Fairleigh Dickinson University | Masters Business Admin |
Seton Hall University School of Law | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Frankrijk | 2 |
Operationeel
General Counsel | 3 |
Corporate Secretary | 2 |
Compliance Officer | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OVID THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Proskauer Rose LLC |
- Beurs
- Insiders
- Thomas Perone
- Ervaring